Skip to content
+1 (800) 559-9921
MRM Proteomics
  • Shop
    • Kits
      • MetaboloMetrics™ Kits
      • PeptiQuant™ Plus Kits
        • Human Plasma
        • Mouse Plasma
        • Quality Control
    • Request a Quote
  • About Us
    • Company
    • Technology
  • Services
    • Service Portfolio
    • Clinical Diagnostics
    • Metabolomics
    • PeptiQuant™ Protein Quantitation
    • Protein Characterization
    • Tissue Imaging
  • Products
    • MetaboloMetrics™ Kits
      • Amino Acids
      • Bile Acids
    • PeptiQuant™ Plus Kits
      • Protein Quantitation
      • Quality Control
    • PeptiCov
  • Workshops
  • News
    • News
    • Events
    • Publications
  • Contact

A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein

Share:

Facebook
Twitter
Google+
LinkedIn
Pinterest

Post navigation

Previous PostTargeted proteomics for evaluating risk of venous thrombosis following traumatic lower-leg injury or knee arthroscopy
Next PostA Non-Hazardous Deparaffinization Protocol Enables Quantitative Proteomics of Core Needle Biopsy-Sized Formalin-Fixed and Paraffin-Embedded (FFPE) Tissue Specimens
sophiab

Written by Sophia Borchers

What are you looking for?

MRM Proteomics Inc. was established in 2010 as a spin-out company to commercialize the cutting-edge proteomics technologies, tools and know-how developed at the University of Victoria-Genome BC Proteomics Centre.

CONTACT

MRM Proteomics Inc.
SB-5100
141, Ave du Président-Kennedy
Montreal, QC, H2X 1Y4 Canada

Tel: +1 (800) 559-9921
Email: info@mrmproteomics.com
URL: www.mrmproteomics.com

QUICK LINKS

Company Technology Services Products News Contact

GENERAL

Terms and Conditions Shipping FAQ Privacy Policy Terms of Use Resources Calendar of Events
2019 © MRM Proteomics. All Rights Reserved | Privacy Policy